Overall Project Abstract Anemia is a major health problem affecting millions of individuals around the world. The overall objective of the proposed program is to develop an improved mechanistic understanding of erythropoiesis, with the goal of defining pathophysiological mechanisms resulting in anemia due to ineffective erythropoiesis. Our overarching hypothesis is that normal human erythropoiesis requires major changes in patterns of gene expression that impact key interconnected pathways in mitosis/cytokinesis, apoptosis, metabolite transport and nuclear structure. Comparisons of these pathways will be performed in a number of important red cell disorders. Four independent but complementary projects that rely on each other have been assembled to explore different aspects of human erythropoiesis. Project 1 will develop a comprehensive mechanistic understanding of the role of changes in gene expression in generating distinct erythroid populations with particular focus on the regulation of erythroid progenitors and late stages of terminal erythroid differentiation including enucleation in normal and disordered erythropoiesis. Project 2 will develop a mechanistic understanding of how the ordered synthesis of distinct proteins is regulated during erythropoiesis by identifying and characterizing enhancers regulating stage-specific programs of gene expression in highly specialized human erythroid cells. In parallel, proteins undergoing mRNA translation at different stages of erythroid development and differentiation will be defined and characterized by ribosomal profiling. Project 3 will develop a mechanistic understanding of the role of cell metabolism in erythroid differentiation. The role of cytokines in erythroid differentiation has been extensively studied but it is only recently that we have begun to recognize the importance of nutrient entry and metabolism in transitioning to different erythroid stages and the proposed project will use a novel scaffold of ligands to metabolite transporters in order to extend our fundamental knowledge of metabolism in erythroid differentiation. These data will reveal novel pathways by which metabolites regulate erythroid lineage differentiation and will result in the identification, and potential manipulation of nutrient transporters that orient erythroid progenitor survival and differentiation in physiological erythropoiesis as well as in the disordered erythropoiesis. Project 4 will develop mechanistic understanding of the role of cell and nuclear stiffness and polarized contractile forces in enucleation, marrow egress, and `self' recognition by macrophages of erythroid cells. The role of lamins, the main nuclear structural proteins in cells, in regulating nuclear rigidity and of myosin-driven cell polarization in these processes will be explored. These insights will result in improved mechanistic understanding of key cellular event during erythroid differentiation.

Public Health Relevance

Anemia is a major health problem affecting millions of individuals around the world. The overall objective of the proposed program is to develop an improved mechanistic understanding of erythropoiesis, with the goal of defining pathophysiological mechanisms resulting in anemia due to ineffective erythropoiesis. Our overarching hypothesis is that normal human erythropoiesis requires major changes in patterns of gene expression that impact key interconnected pathways in mitosis/cytokinesis, apoptosis, metabolite transport and nuclear structure. Comparisons of these pathways will be performed in disordered human erythropoiesis due to thalassemia, Diamond-Blackfan anemia (DBA), congenital dyserythropoietic anemia and myelodysplastic syndrome (MDS). Four independent but complementary projects that rely on each other and two cores for key materials and intellectual exchanges have been assembled to explore different aspects of human erythropoiesis. Project 1 will develop a comprehensive mechanistic understanding of the role of changes in gene expression in regulating normal and disordered human erythropoiesis. Project 2 will develop a mechanistic understanding of how the ordered synthesis of distinct proteins is regulated during erythropoiesis by identifying and characterizing enhancers regulating stage-specific programs of gene expression and by ribosomal profiling in highly specialized human erythroid cells. Project 3 will develop a mechanistic understanding of the role of cell metabolism in erythroid differentiation. Project 4 will develop mechanistic understanding of the role of cell and nuclear stiffness and polarized contractile forces in enucleation, marrow egress, and `self' recognition by macrophages of erythroid cells. Two scientific cores, the cell biology core and the bioinformatics core, will ensure that all four projects have access to uniform samples of highly enriched populations of human erythroiod cells at distinct development stages and that all four projects have access to state of the art bioniformatic analysis capabilities, respectively. An administrative core will provide organizational assistance to the program. A major strength of the proposed program is the effective integration of various novel conceptual concepts and state-of-the-art methodological approaches to study the complex biological process of erythropoiesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
5P01DK032094-32
Application #
10013226
Study Section
Special Emphasis Panel (ZDK1)
Program Officer
Bishop, Terry Rogers
Project Start
1997-01-30
Project End
2022-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
32
Fiscal Year
2020
Total Cost
Indirect Cost
Name
New York Blood Center
Department
Type
DUNS #
073271827
City
New York
State
NY
Country
United States
Zip Code
10065
Qu, Xiaoli; Zhang, Shijie; Wang, Shihui et al. (2018) TET2 deficiency leads to stem cell factor-dependent clonal expansion of dysfunctional erythroid progenitors. Blood 132:2406-2417
Huang, Yumin; Hale, John; Wang, Yaomei et al. (2018) SF3B1 deficiency impairs human erythropoiesis via activation of p53 pathway: implications for understanding of ineffective erythropoiesis in MDS. J Hematol Oncol 11:19
Ali, Abdullah Mahmood; Huang, Yumin; Pinheiro, Ronald Feitosa et al. (2018) Severely impaired terminal erythroid differentiation as an independent prognostic marker in myelodysplastic syndromes. Blood Adv 2:1393-1402
Yan, Hongxia; Hale, John; Jaffray, Julie et al. (2018) Developmental differences between neonatal and adult human erythropoiesis. Am J Hematol 93:494-503
Han, Xu; Zhang, Jieying; Peng, Yuanliang et al. (2017) Unexpected role for p19INK4d in posttranscriptional regulation of GATA1 and modulation of human terminal erythropoiesis. Blood 129:226-237
Gastou, Marc; Rio, Sarah; Dussiot, Michaƫl et al. (2017) The severe phenotype of Diamond-Blackfan anemia is modulated by heat shock protein 70. Blood Adv 1:1959-1976
Irianto, Jerome; Pfeifer, Charlotte R; Xia, Yuntao et al. (2016) SnapShot: Mechanosensing Matrix. Cell 165:1820-1820.e1
Pimentel, Harold; Parra, Marilyn; Gee, Sherry L et al. (2016) A dynamic intron retention program enriched in RNA processing genes regulates gene expression during terminal erythropoiesis. Nucleic Acids Res 44:838-51
Ivanovska, Irena L; Shin, Jae-Won; Swift, Joe et al. (2015) Stem cell mechanobiology: diverse lessons from bone marrow. Trends Cell Biol 25:523-32
Dasbiswas, K; Majkut, S; Discher, D E et al. (2015) Substrate stiffness-modulated registry phase correlations in cardiomyocytes map structural order to coherent beating. Nat Commun 6:6085

Showing the most recent 10 out of 311 publications